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BACKGROUND: Papillary thyroid cancer (PTC) incidence increased dramatically in children after the Chernobyl accident, providing a
unique opportunity to investigate the molecular features of radiation-induced thyroid cancer. In contrast to the previous studies that
included age-related confounding factors, we investigated mRNA expression in PTC and in the normal contralateral tissues of
patients exposed and non-exposed to the Chernobyl fallout, using age- and ethnicity-matched non-irradiated cohorts.
METHODS: Forty-five patients were analysed by full-genome mRNA microarrays. Twenty-two patients have been exposed to the
Chernobyl fallout; 23 others were age-matched and resident in the same regions of Ukraine, but were born after 1 March 1987,
that is, were not exposed to 131I.
RESULTS: A gene expression signature of 793 probes corresponding to 403 genes that permitted differentiation between normal
tissues from patients exposed and from those who were not exposed to radiation was identified. The differences were confirmed by
quantitative RT-PCR. Many deregulated pathways in the exposed normal tissues are related to cell proliferation.
CONCLUSION: Our results suggest that a higher proliferation rate in normal thyroid could be related to radiation-induced cancer either
as a predisposition or as a consequence of radiation. The signature allows the identification of radiation-induced thyroid cancers.
British Journal of Cancer (2012) 107, 994–1000. doi:10.1038/bjc.2012.302 www.bjcancer.com
Published online 24 July 2012
& 2012 Cancer Research UK
Keywords: thyroid; radiation; gene expression; Chernobyl























































Thyroid cancer is the most common form of solid neoplasm
associated with radiation exposure. There has been a considerable
increase in occurrence of papillary thyroid carcinomas (PTCs)
after the Chernobyl power plant explosion, particularly in children
and adolescents (Baverstock et al, 1992). This increase in incidence
(up to a 100-fold) is present only in the areas of Belarus, Ukraine
and Russia that lie closest to the site of the Chernobyl nuclear
power plant. The incidence of thyroid cancer in these age groups is
very low in unexposed populations, which provides some evidence
that the majority of thyroid cancers occurring in this population is
a direct result of exposure to radiation (Malone et al, 1991). In
radiation-induced PTC, the histology and disease stage are related
to the young age of patients rather than to the triggering event
(Williams et al, 2004; Jarzab et al, 2005a). Spontaneous and post-
Chernobyl PTC are characterised by the constitutive activation of
effectors along the RAS-RAF-MAP kinase signalling pathway: in
adult PTC, BRAF somatic mutations (frequency: 36–69%) and
RET/PTC rearrangements (frequency: o30%) represent the most
common genetic alterations (Cohen et al, 2003; Kimura et al, 2003;
Soares et al, 2003). In paediatric PTC (spontaneous and
radio-induced), RET/PTC rearrangements are the most prevalent
alteration (60–80%), while BRAF point mutation is only observed
in about 4% of the cases (Nikiforov, 2002; Xing, 2005).
A number of different studies have been undertaken that set out
to identify a radiation signature by comparing sporadic PTC,
whose ethiology is unknown, and radiation-induced PTC. So far,
four transcriptomic studies comparing radiation-induced and
spontaneous thyroid cancer have been reported. We have shown
that post-Chernobyl PTC had the same global molecular pheno-
type as spontaneous PTC (Detours et al, 2005; Detours et al, 2007).
However, they were distinguishable with molecular signatures of
responses to g-radiation and H2O2, and with genes involved in
homologous recombination (Detours et al, 2007). In another study,
Port et al (2007) reported seven genes that discriminated post-
Chernobyl from German spontaneous PTC. Recently, by investi-
gating copy number and gene expression alterations in post-
Chernobyl PTC, Stein et al (2010) identified 141 gene expression
changes presented as potential biomarkers of radiation exposure to
the thyroid. As mentioned by the authors themselves, these studies
harbour potential confounding factors, namely the age and the
ethnicity of the patients, because young post-Chernobyl patients
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were compared with adult Western European patients. Hence,
besides age, differences in iodine supply, heterogeneity of stage and
pathological variant-related factors may explain the reported
differences in gene expression. Moreover, the overlap between those
studies in term of radiation-specific signatures is quite low.
The prospective collection of thyroid tumours from patients
who were born after the Chernobyl accident by the Chernobyl
Tissue Bank (CTB) (www.chernobyltissuebank.com) provides a
unique opportunity to compare exposed and non-exposed cases,
but this time with age- and ethnicity-matched cohorts. This
approach, trying to minimise variability linked to age and
ethnicity, has resulted in the identification of a gain of chromo-
some band 7q11 associated with radiation exposure (Hess et al,
2011). In the study reported here, we compared the gene
expression profiles of the normal contralateral tissues of PTC
patients exposed and not exposed to radioiodine in the fallout
from Chernobyl. This analysis provides the opportunity to assess
the existence of a susceptibility to radiation that could be
responsible for tumour development. We report the identification
of a gene expression signature that permits discrimination between
exposed and non-exposed normal thyroid tissues.
MATERIALS AND METHODS
Tissue samples
Paired RNA samples of tumoural and non-tumoural thyroid
tissues were obtained from Ukraine via the CTB (n¼B150
www.chernobyltissuebank.com). Diagnoses were confirmed by the
members of the International Pathology Panel of the CTB. The
CTB is an established research tissue bank and is approved by both
the Institutional ethics committees of the contributing organisa-
tions (in the case of this study, the Institute of Endocrinology
and Metabolism, Kiev and Imperial College London), and by
the Institutional Review Board of the National Cancer Institute of
the United States. The available patient information, clinical and
gene alteration data relative to these samples are presented in
Supplementary Table 1. RNA quality was assessed using
an automated gel electrophoresis system (Experion, Bio-Rad
Laboratories, Nazareth Eke, Belgium). The presence of RET/PTC
rearrangement or BRAF mutation in tumours was based on real-
time quantitative RT-PCR (qRT-PCR) (Taqman) analyses, and
genomic DNA sequencing after PCR amplification of exon 15,
respectively (Powell et al, 2005).
Microarray experiments
The quality of RNA was assessed using an automated electrophor-
esis system (Experion, Bio-Rad). Only samples with RNA Quality
Indicator (RQI) 47.5 were kept for the microarray analyses
(for most samples: RQI 48.5/9).
RNA amplification, and cDNA synthesis and labelling were
performed following Affymetrix (Santa Clara, CA, USA) protocol.
Two micrograms of RNA from 22 paired RNA samples from
exposed thyroid tissues (tumour and adjacent tissue) and from 23
paired RNA samples from non-exposed thyroid tissues, together
with five additional non-exposed tumour samples were hybridised
on Affymetrix Human Genome U133 Plus 2.0 Arrays.
Analysis of expression data
CEL file data were subjected to normalisation by GCRMA.
Hierarchical clustering and principal component analysis (PCA)
were conducted with GenePattern (http://www.broad.mit.edu/
cancer/software/genepattern/) (Reich et al, 2006). Significance
Analysis Of Microarray (SAM) (Tusher et al, 2001) was used to
search for single gene expression differences (1000 permutations),
and GSEA (GenePattern, MsigDB) to search for multigene
signatures allowing to distinguish classes (Subramanian et al,
2005). Class prediction based on leave-one-out cross-validation
was performed with the k-nearest neighbours algorithm
(KNNXValidation, GenePattern), and two supervised classification
algorithms were also used to search for the best classifiers, in R
version 2.11.1: Support Vector Machine (SVM, packages e1071
1.5–24) (Meyer, 2011) and Random Forest (RF, package random-
Forest 4.6-2) (Liaw, 2011). They were used in an inner/outer cross-
validation as implemented in the MCRestimate (2.4.0) package
(Ruschhaupt, 2004) with parameters of partition ci¼ 5 and
co¼ 10, and repeats cr¼ 10. Different ranges of parameters for
each algorithm were tuned in the inner cross-validation loop: VAR
numbers in {23, 25, 27), SVM cost equal to 0.01 or 0.1), RF node size
equal to 5 or 7. As a negative control the entire inner/outer cross-
validation loop was repeated with 100 permutations of the sample
labels, which gave an approximation of the P-value for the correct
classification rate. As a positive control, the entire cross-validation
loop was used to classify the samples regarding the sex of the
patients, a classification task for which there should exist a perfect
linear separation in the normal.
Covariate adjustment
The expression of each gene was decorrelated with respect to the
age at operation by taking the residuals of a robust linear fitting
model with respect to the age at operation for each gene (package
MASS: function lqs method lqs).
Real-time qRT-PCR
Validation of microarray results was performed by real-time
qRT-PCR (SYBR green method) (Eurogentec, Liege, Belgium). The
primers were designed with the Primer-3 software (http://
frodo.wi.mit.edu/primer3/) and are listed in Supplementary
Table 2. All PCR efficiencies, obtained with four or five serial
dilutions points (ranging from 20 ng to 20 or 200 pg), were above
90% and real-time qRT-PCR was performed in duplicate for each
gene. NEDD8 and TTC1 expressions were used to normalise the
data, as described previously (Delys et al, 2007).
RESULTS
Exposed and non-exposed tumours and normal adjacent
tissues have similar global expression profiles
About 150 thyroid tissues samples were received from the CTB.
Samples showing RQI below 7.5 were excluded from the study and
95 samples were kept for further analysis: 45 tumour/normal
paired tissues (22 exposed, 23 non-exposed) and 5 tumours from
non-exposed tissues for which the normal counterpart was not
available. The samples were hybridised onto Affymetrix Human
Genome U133 Plus 2.0 Arrays.
We first searched for global expression differences between
exposed and non-exposed normal and tumour tissues, that is,
extensive differences detectable when all the genes present on our
arrays were considered. To search for biologically relevant
subgroups among the samples, unsupervised analyses, including
hierarchical clustering and PCA, were conducted. Both analyses
showed a perfect separation between normal and tumour tissues
(Figure 1). To look for consistent upregulated or downregulated
genes across tumour and normal tissues, we used supervised
methods such as SAM, which revealed 22 289 probes that
significantly differentiated tumour and normal tissues. Thus, a
large fraction of the transcriptome was significantly differently
regulated in PTCs compared with normal thyroid tissues
(FDR o5%).
To validate our microarray data, the modulation of the following
eight genes, four upregulated and four downregulated in tumours
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compared with normal tissues, was investigated by qRT-PCR:
carbonic anhydrase 12, BH3-interacting domain death agonist,
clusterin, cyclin D2, trefoil factor 3, low-density lipoprotein
receptor-related protein 1B, dual specificity phosphatase 1
(DUSP1) and thrombospondin, type I, domain-containing 7A.
These genes were selected because they were already identified as
being important in carcinogenesis. Expressions were normalised
with TTC1 and NEDD8, which were identified in a previous work
as being the best normalisation genes for PTC, resulting from their
very stable, non-regulated, expression across the samples (Delys
et al, 2007). Similar modulation patterns were found for the
expression of the eight genes comparing microarray analyses with
qRT-PCR (Supplementary Figure 1).
When considering all probes, hierarchical clustering and PCA
did not separate exposed and non-exposed samples (Figure 1).
Exposed and non-exposed samples did not separate either when
the analysis was performed with only the normal samples or only
the tumour samples. Similarly, pairing the tumour and normal
samples from the same patient and considering the tumour/normal
gene expression ratios led to the same result (data not shown).
However, this does not exclude that a subset of genes might
distinguish them. We investigated this hypothesis by conducting
supervised analyses.
SAM analyses revealed differences between exposed
and non-exposed normal tissues
Before the supervised analyses, we looked for the presence
of potential confounding factors that may bias the results if they
were unequally distributed within the two considered groups, that
is, give a gene expression signature unrelated to the exposed/
non-exposed conditions. We performed a systematic study of the
following data (Supplementary Table 1): sex (25% males for
exposed and 20% males for non-exposed), age at operation
(median age at operation: 17 for exposed and 16.5 for non-
exposed), date of operation, geographical origin (oblast) of the
patients, PTC morphological subtype, TNM classification, presence
of BRAF mutation or RET/PTC rearrangement, tumour size,
percentage of epithelial cells in the samples, percentage of
lymphocytic infiltration, localisation of the surgical pieces in the
thyroid gland, RNA quality (small differences in RQI between
exposed and non-exposed samples), hybridisation series (five
different batches) and freezing time of the frozen tissue samples
before RNA extraction. Only two factors were significantly
associated with the radiation exposure status: the length of storage
of frozen tissue samples before RNA extraction and the age of the
patients at operation. The freezing time was for obvious reasons
longer for the exposed samples, but there was no significant
correlation between the storage length of the frozen tissue samples
before RNA extraction and their quality (data not shown).
Regarding age at operation, there was a small but significant
difference (median: 6 months, P¼ 0.006) between the groups
of exposed and non-exposed samples (Supplementary Figure 2).
Significance Analysis of Microarray analysis identified genes with
expression significantly associated with age. Data were adjusted in
Prin.
Comp. 2
Prin.
Comp. 1
Prin.
Comp.3
Normal exposed
Tumours non-exposed
Normal non-exposed
Tumours exposed
Figure 1 Global gene expression profiles of exposed and non-exposed
normal and tumour tissues: PCA of the microarray data plotted with respect
to first, second and third principal components. All probes were considered
for the analysis. Tumour samples are shown in green (exposed) and in yellow
(non-exposed), and normal samples are shown in red (exposed) and in blue
(non-exposed). Abbreviation: Prin. Comp.¼ principal component.
qRT-PCR
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Figure 2 Comparison of differential gene expression data obtained by microarrays and qRT-PCR on exposed and non-exposed normal tissues.
The upper and lower limits of each box stand for the upper and the lower quartiles, respectively; bold lines represent medians; and whiskers represent the
10–90 percentiles. Regulation of serpine peptidase inhibitor clade E (SERPINE1), DUSP1, tribbles homologue 1 (TRIB1), calcium-binding protein A10
(S100A10), retinol dehydrogenase 12 (RDH12), annexin A1 (ANXA1) and guanine nucleotide-binding protein G(olf) subunit alpha (GNAL) was confirmed
on 13 exposed normal contralateral tissues and 20 non-exposed normal contralateral tissues.
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order to remove age-related signals from the expression data
(Materials and Methods). A hierarchical clustering on the age-
adjusted data showed a perfect distinction between normal and
tumour tissues, but still no distinction between exposed and non-
exposed tissues (Supplementary Figure 3).
Significance Analysis of Microarray was used to compare
exposed vs non-exposed tissues, on the age-adjusted data and
identified differentially expressed genes between the normal
tissues. Indeed, 793 probes, representing 403 genes, for the
age-adjusted data (500 probes for the non-age-adjusted data)
were found to be significantly upregulated in the exposed normal
tissues (qo0.05, q is a multiple-testing-adjusted confidence
measure) (Supplementary Table 3, shows the 50 most regulated
genes). Twenty-eight of these genes had a fold change higher
than 2 (overall mean fold change: 1.53). No probe was found to be
downregulated in the exposed normal tissues.
Quantitative RT-PCR analysis confirmed the expression differ-
ences for seven genes, that is, serpine peptidase inhibitor clade E,
DUSP1, tribbles homologue 1, S100 calcium-binding protein A10,
annexin A1, guanine nucleotide-binding protein G(olf) subunit
alpha and retinol dehydrogenase 12, with similar modulation
patterns for mRNA expression comparing microarray with
qRT-PCR analyses (Figure 2).
When SAM was performed to compare age-adjusted expression
values of exposed and non-exposed tumour samples, no
significantly upregulated or downregulated probes were detected.
Validation with an external data set
The reliability of our signature was supported by similar results
obtained with an external data set. Data sets for validation are very
limited; however, in the context of a European Union-coordinated
consortium, GENRISK-T, gene expression analyses on exposed
and non-exposed samples were also carried out in the laboratory
of B Jarzab (Poland). Owing to technical study/lab differences,
microarrays profiles could not be meaningfully compared at
the level of individual genes (Tamayo et al, 2007). Consequently,
we used our 793 probes as a gene set and evaluated their collective
expression with GSEA in the Polish data set. Collectively, these
genes were regulated in the same direction in a significant manner
(P¼ 0.004, NES¼  1.773) (Supplementary Figure 4). These
results showed that our signature was not restricted to our data set.
Biological meaning of the 793 probe signature
Investigations of the biological meaning of these 793 probes
differentially expressed between normal non-exposed and exposed
tissues were conducted with the DAVID (Database for Annotation,
Visualisation and Integrated Discover) software (Dennis et al,
2003), which finds the most represented pathways or functions
according to gene annotation databases such as KEGG and
Gene Ontology. The most significantly altered KEGG pathways
were related to cancer or proliferation, and included MAPK,
insulin and mTOR signalling pathways, as well as cell adhesion,
suggesting the presence of a proliferation signal in the trans-
criptome of the exposed normal tissues (Table 1).
The main global molecular functions that were significantly
enriched in exposed normal samples were linked to nucleic acid
processing, also suggesting a proliferative activity (Supplementary
Table 4).
Supervised machine-learning classifiers distinguished
exposed and non-exposed normal tissues with 30% error
Supervised machine-learning algorithms were used to search for a
gene expression signature that predicts class membership for
exposed and non-exposed normal tissues. K-nearest neighbours
classification with leave-one-out cross-validation was chosen in a
first approach. The classification was run with the whole set of
probes. Sixty-seven percentage of our samples were correctly
classified. Furthermore, accuracies of 69% and 71% were obtained
using two other linear classification algorithms, respectively, SVM
and RF, and an inner/outer cross-validation protocol designed to
prevent parameter and feature selection biases (Table 2). To
control whether chance alone could explain these accuracies, the
entire SVM and RF cross-validation loops were repeated with 100
random permutations of the sample labels. Equal or better
accuracies were obtained for zero and three permutations,
respectively. As a positive control, we used the exact same
procedure to classify patients according to sex and obtained a
100% accuracy bringing perspective on the limits of the radiation-
related transcriptional signal present in normal tissues.
DISCUSSION
The aim of this study was to investigate gene expression profiles in
thyroid tumours that have arisen in the population exposed to the
radioactive fallout from the Chernobyl accident (i.e., born before
26 April 1986), and to compare them with profiles of tumours of
similar pathology, arising in an age-matched population, residing
in the same geographical area, and born after 1 March 1987. Thus,
contrary to previous studies, this work included a carefully
matched control group and investigated a larger number of
patients. Both tumours and their contralateral normal tissues were
analysed in order to reveal a radiation signature. Although we may
not exclude that our exposed cohort might contain some
spontaneous PTC, they have been estimated to be o15% of the
cases (Hess et al, 2011).
The microarray expression data confirmed previous results
showing that a very large fraction of the transcriptome was
dysregulated in the tumours (Huang et al, 2001; Jarzab et al, 2005b;
Delys et al, 2007; Maenhaut et al, 2011). On a global scale, whereas
unsupervised analyses clearly distinguished normal and tumour
Table 1 KEGG pathways enriched in exposed normal tissues and
statistical significance following the analysis of the 793 probes signature with
DAVID software
Term PVal FDR
hsa05220: Chronic myeloid leukaemia 8.89E 06 0.010354846
hsa04722: Neutrophin signalling pathway 2.28E 05 0.02649372
hsa04010: MAPK signalling pathway 1.32E 04 0.153409419
hsa 04910: Insulin signalling pathway 2.32E 04 0.270422672
hsa05211: Renal cell carcinoma 6.64E 04 0.770791067
hsa05212: Pancreatic cancer 8.19E 04 0.949136812
hsa04810: Regulation of actin cytoskeleton 0.00126321 1.461223451
hsa03040: Spliceosome 0.00139603 1.613718043
hsa04150: mTOR signalling pathway 0.00201986 2.327103458
hsa04210: Apoptosis 0.00314594 3.602869581
hsa04510: Focal adhesion 0.00424634 4.834818104
Abbreviations: DAVID¼Database for Annotation, Visualisaion and Integrated
Discover; FDR¼ false discovery rate; MAPK¼mitogen-activated protein kinase;
mTOR¼mammalian target of rapamycin.
Table 2 Error rates for supervised classification (based on all genes)
Classification
algorithm
Exposed
error
Non-exposed
error
Global
error
KNNXValidation 27 39 33
SVM 27 35 31
RF 31 26 29
Abbreviations: KNNXValidation¼ K-nearest neighbours classification with leave-one-
out cross-validation; SVM¼ Support Vector Machine; RF¼Random Forest.
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tissues, no distinction between the transcriptomes of exposed and
non-exposed samples was observed. However, when using a
supervised approach, SAM, differentially expressed genes between
exposed and non-exposed normal tissues were detected, that is,
a gene expression signature that permits discrimination between
both types of samples. Such a difference was not observed among
the tumours, probably because the latter have evolved into very
diversified phenotypes, depending on the initial mutation, the local
environment and other factors, and accordingly, are more
heterogeneous (Figure 1). Thus, we may not exclude that
differentially expressed genes might be revealed if a larger set of
tumour samples was investigated.
Although age-matched patients were used in this study, contrary
to the previous transcriptomic studies on radiation-induced thyroid
cancer (Detours et al, 2005; Detours et al, 2007; Port et al, 2007;
Stein et al, 2010), age was still a potential confounder with a median
age difference of 6 months between the exposed and non-exposed
patients. Consequently, the data were age-adjusted, that is, corrected
for the correlation between age and gene expression. Age matching
and age adjustment are important for several reasons. First, it has
been observed that the incidence of thyroid cancer varies with age
and is uncommon among children in normal conditions. Second,
the risk of developing thyroid cancer after radiation exposure is
higher during childhood, that is, the effects of radiation exposure on
thyroid cancer development are age-dependent (Cardis et al, 2005).
This is consistent with the decrease of thyroid cell proliferation with
age (Coclet et al, 1989; Saad et al, 2006). Third, genetic alterations
present in PTC vary with age, RET/PTC rearrangements being the
most common abnormalities described in paediatric sporadic and
radiation-induced PTC.
Seven hundred and ninety-three probes, corresponding to 403
genes, were shown to be differentially expressed between normal
exposed and non-exposed samples in the age-adjusted data set.
Although the overall differences in gene expression between the
two groups were rather small, they were statistically significant
(qo0.05) and were confirmed by qRT-PCR for seven genes. In the
field of carcinogenesis, Bozic et al (2010) showed that tumour
development could result from the accumulation of multiple driver
and passenger mutations, while each mutation on its own only has
a little contribution to the process of cancer development.
Similarly, multiple small gene expression differences could be
the basis of susceptibility in our study of radiation-related PTC,
and this signature may allow the identification of radiation-
sensitive individuals.
There are so far no clear arguments that demonstrate that
radiation affects everyone equally, and the propensity to develop
cancer following exposure is likely to be variable. A genetic analysis
of radiation-induced gene expression changes in immortalised
human lymphocytes showed an extensive individual variation for
several genes (Smirnov et al, 2009). Differences in genetic back-
ground underlie variation in the susceptibility to the effects of
radiation in normal tissues (Chuang et al, 2006; Barnett et al, 2009).
A recent genome-wide association study (Takahashi et al, 2010)
compared 500 000 polymorphisms in patients with PTC and in
healthy Belarusian and Ukrainian subjects, all exposed to radiation
from the Chernobyl fallout. An association between PTC and a
polymorphism near the FOXE1 gene (TTF2) was found, but this
polymorphism had also been reported previously in a non-
irradiated Icelandic population (Gudmundsson et al, 2009). This
study, however, had no demographically and ethnically matched
control group of non-irradiated PTC patients. Thus, while it
pointed out that radiation-induced and spontaneous PTC share the
FOXE1 suceptibility loci, this study design could not unambigu-
ously conclude on radiation-specific cancer predisposition loci.
Investigations about the biological meaning of our 793 probes
signature highlighted significantly altered proliferation pathways,
suggesting that the exposed normal tissues exhibit a proliferation
signal in their transcriptome. This suggests that a higher
proliferation rate would predispose to cancer after irradiation.
Evidence of an association of the proliferative activity in thyroid
cells with a risk of cancer after radiation exposure has been
reported and may explain the higher risks of radiation-related
thyroid cancer in children compared with adults (Saad et al, 2006).
The levels of radiation observed after the Chernobyl accident were
low to moderate, but no precise and individual radiation doses are
available.
This signature might reflect radiation susceptibility, but various
alternative interpretations should be considered. First, this
signature might be a consequence of radiation. Radiation has
potential DNA damaging and carcinogenic effects, and causes
single- and double-strand breaks. Double-strand breaks are
thought to be particularly important for cancer development,
and represent the major effect of b-radiation, for example, 131I,
although the radiation effects are complex and numerous
(Bourguignon et al, 2005; Harper and Elledge, 2007; Riley et al,
2008). However, DNA damage is repaired within the few hours or
days after radiation exposure, and our signature would then reflect
the long-lasting consequences of incorrectly repaired DNA
damage. This damage would still be present in the normal tissues,
but not severe enough to have induced tumourigenesis without
(an) additional mutation(s) that generated the initial cancer cells.
To investigate whether radiation-related signatures could be
detected in our samples, we constructed gene sets with radiation
signatures published previously following analyses of post-
Chernobyl PTC (Detours et al, 2007; Port et al, 2007; Stein et al,
2010; Ugolin et al, 2011) and used them in a GSEA-type analysis.
None of them was found to be enriched in exposed or non-exposed
normal tissues (Supplementary Table 5).
Second, this signal could be owing to the presence of
microcarcinomas in the exposed normal tissues, as a result of
radiation (Hayashi et al, 2010). This hypothesis is, however, unlikely,
as analysis of many cases of the irradiated cohort by a panel of
internationally recognised pathologists showed no evidence of an
increase in microcarcinomas in this group. Moreover, to be
detectable in whole-tissue gene expression analyses, such a presence
should involve a significant part of the cell population.
Third, differences in iodine intake between the two cohorts might
explain the signature. This proliferation signal could indeed be
related to iodine deficiency or differential gland stimulation. It was
proposed by some authors (Malone et al, 1991; Williams et al, 2008)
that the morphological characteristics of Chernobyl-related
childhood PTC were related to iodine intake and independent of
radiation exposure. However, the existence of a difference in iodine
dietary between the two studied Ukrainian cohorts is unlikely:
Ukraine was iodine deficient before the Chernobyl disaster and is
still deficient today, according to ICCIDD (International Council for
Control of Iodine Deficiency Disorders) (www.iodinenetwork.net/
documents/scorecard-2010.pdf) and to UNICEF. In addition, the
majority of our exposed cases were between 0 and 2 years old at
exposure, that is, born between 1984 and 1986, while most
non-exposed cases were born between 1987 and 1990. The median
date at operation was end 2001 for the exposed group and mid-2006
for the non-exposed group. Thus, the two groups had widely
overlapping lifespan before surgery, and were therefore raised
mostly in comparable historical context regarding iodine avail-
ability. Of course, these are global observations, and we cannot
exclude individual differences in iodine intake.
Furthermore, as iodine deficiency results in an increase in TSH
levels and in thyrocyte proliferation, we compared our signature
with reported transcriptional signatures characterising stimulated
thyroid tissues such as autonomous adenomas and familial non-
autoimmune hyperthyroidism (Hebrant et al, 2009), or thyroid
disorders linked to iodine deficiency such as follicular thyroid
cancers. None of them was enriched in our exposed versus non-
exposed normal tissues, again suggesting that our signature does
not reflect differences in iodine dietary (data not shown).
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In conclusion, by comparing the transcriptomes of normal
contralateral tissues of PTC occurring in children exposed and
non-exposed to the Chernobyl fallout, we have identified a gene
expression signature that permits discrimination between both
cohorts. This signature suggests the existence of a higher
proliferation rate in the exposed normal thyroid tissues, which
might predispose to cancer after radiation. Whether the signature
reflects a susceptibility to radiation or a late effect of radiation, it
gives, for a given tissue, an indication that the carcinoma was
sporadic or caused by irradiation. It also suggests that decreasing
the already slow renewal rate of thyroid cells (Coclet et al, 1989) by
a preventive thyroxine treatment, suppressing the major trophic
stimulus TSH, could prevent radiation-induced thyroid cancer. Of
course, this hypothesis deserves to be tested.
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